Annals of medicine

Ann Med · ISSN (e) 1365-2060 · 22 papers in corpus
article 2026
doi:10.1080/07853890.2026.2617748 ·PMID:41560449
article 2026
doi:10.1080/07853890.2026.2617758 ·PMID:41620843
article 2026
doi:10.1080/07853890.2026.2620857 ·PMID:41614571

PURPOSE: Adenomyosis (AM) with dysmenorrhea (AMD) is a global public health concern that may involve abnormal brain function and heightened vulnerability to anxiety and depression. This study aimed to investigate static and dynamic regional…

article 2025
doi:10.1080/07853890.2025.2523563 ·PMID:40579858

BACKGROUND: Endometriosis, a chronic immune-mediated inflammatory disease, remains elusive in its pathogenesis. Given vitamin D (VD)'s pivotal role in modulating innate and adaptive immune responses, we sought to elucidate how VD modulates …

article 2025
doi:10.1080/07853890.2025.2550579 ·PMID:40916542

OBJECTIVE: To evaluate preoperative serum calcium levels and their association with deep infiltrating endometriosis (DIE) in ovarian endometrioma. DESIGN: A retrospective, observational cohort study. PARTICIPANTS: A total of 2,557 women who…

article 2025
doi:10.1080/07853890.2025.2534521 ·PMID:40708430

BACKGROUND: Extrinsic adenomyosis exhibits heterogeneous clinical symptoms, with pain being more commonly reported. The relationship between magnetic resonance imaging (MRI) feature and symptom remains unclear. OBJECTIVE: To evaluate the pe…

article 2025
doi:10.1080/07853890.2025.2564913 ·PMID:41360706
review 2025
doi:10.1080/07853890.2025.2570794 ·PMID:41388722

AIMS: Progestins are a group of substances with a wide range of applications. They are classified into pregnanes, estranes, and gonanes, and further divided into four generations based on their testosterone (TE) or progesterone (P4) origin.…

other 2025
doi:10.1080/07853890.2025.2527352 ·PMID:40641309

BACKGROUND: Pelvic pain secondary to endometriosis is a disabling condition. There are multiple treatments available, with variable endpoints. No prospective controlled studies were carried out evaluating subdermal pellets of gestrinone in …

article 2025
doi:10.1080/07853890.2025.2596541 ·PMID:41330878
article 2025
doi:10.1080/07853890.2025.2583543 ·PMID:41220042

BACKGROUND: Endometriosis-associated ovarian cancer (EAOC) mainly includes endometrioid ovarian cancer (ENOC) and clear cell ovarian cancer (CCOC). The Cancer Genome Atlas (TCGA) revealed four molecular subtypes of endometrial cancer (EC) i…

article 2024
doi:10.1080/07853890.2024.2402942 ·PMID:39324359

OBJECTIVE: This prospective observational study aims to demonstrate the clinical efficacy of dienogest in treating endometriomas with a maximum diameter of ≥4 cm. METHODS: = 81) with endometriomas (diameter of ≥4 cm) were enrolled and admin…

other 2023
doi:10.1080/07853890.2023.2281510 ·PMID:37994446

OBJECTIVE: To investigate the outcome of total laparoscopic hysterectomy (TLH) and postoperative pain characteristics and compare the pain severity after TLH for adenomyosis or uterine fibroids. METHODS: This prospective observational stud…

other 2023
doi:10.1080/07853890.2023.2244877 ·PMID:37624743

OBJECTIVE: The present study aims to investigate the clinical and histopathological features of peritoneal endometriosis (PEM) and deep infiltrating endometriosis (DIE). METHODS: A total of 100 patients with PEM and DIE admitted to Dalian …

article 2023
doi:10.1080/07853890.2023.2243825 ·PMID:37572646

OBJECTIVE: To explore potential biomarkers indicating endometriosis (EM). MATERIALS AND METHODS: A proteomics method and combined quantitative transcriptomics were adopted to highlight markers in the EM. Venn analysis was used to integrate …

article 2023
doi:10.1080/07853890.2023.2215537 ·PMID:37254517

Objectives Patients often search for health-related information on the internet allthough this trend may have some benefits, it also has some risks, such as misinformation. The aim of this study is to evaluate how Internet information seeki…

article 2022
doi:10.1080/07853890.2022.2071458 ·PMID:35535701

Objective To explore the role of postoperative gonadotrophin releasing hormone agonist (GnRH-a) therapy before treatment with intrauterine insemination (IUI) for infertile females with stage I-II endometriosis.Material and methods Ninety-se…

article 2022
doi:10.1080/07853890.2022.2074534 ·PMID:35733415

Background To clarify clinical importance of serum CA19-9, CA-125, and plasma D-dimer (D-D) levels in detecting spontaneously ruptured ovarian endometriosis (OE).Materials and Methods We retrospectively examined 173 patients with endometrio…

article 2021
doi:10.1080/07853890.2021.1991589 ·PMID:34714186

INTRODUCTION: The SARS-CoV-2 pandemic has forced healthcare providers to reorganize their activities to protect the population from infection, postponing or suspending many medical procedures. Patients affected by chronic conditions were am…

article 2021
doi:10.1080/07853890.2021.1966087 ·PMID:34409913

Aim Endometriosis is one of the most common reproductive system diseases, but the mechanisms of disease progression are still unclear. Due to its high recurrence rate, searching for potential therapeutic biomarkers involved in the pathogene…

review 1998
doi:10.3109/07853899809002599 ·PMID:9920353

The possibility that ovulation induction increases the risk of ovarian cancer remains unproven. However, recent studies suggest that both infertility and endometriosis may be independent risk factors. Despite the various case reports and ep…

review 1990
doi:10.3109/07853899009147249 ·PMID:2193663

The relationship of endometriosis, the most common benign gynaecological disease during reproductive life, to infertility is generally ill understood. The association between infertility and minimal to mild endometriosis, when no anatomical…